Results 231 to 240 of about 2,221,794 (256)
Some of the next articles are maybe not open access.
Decitabine for acute myeloid leukemia
Expert Review of Anticancer Therapy, 2012Decitabine (Dacogen(®), Eisai Inc., NJ, USA) is a nucleoside analogue DNA methyltransferase inhibitor first synthesized and documented to have antileukemic efficacy over 40 years ago. Over the years, the dosing of decitabine has been refined, such that for acute myeloid leukemia, a 5-day schedule of 20 mg/m(2) is now commonly utilized.
openaire +2 more sources
Onconephrology: The Intersections Between the Kidney and Cancer
Ca-A Cancer Journal for Clinicians, 2021Blaithin A McMahon +2 more
exaly
Epigenetics in Acute Myeloid Leukemia
Medical Epigenetics, 2016Carmela Dell'Aversana, Lucia Altucci
exaly
Treatment of Acute Leukemia:Current Results, and Analysis of What We Can Do Now
Ca-A Cancer Journal for Clinicians, 1964Margaret P Sullivan, Wataru W Sutow
exaly
Acute Leukemia in Adults: Recent Developments in Diagnosis and Treatment
Ca-A Cancer Journal for Clinicians, 1994Steven M Devine, Richard A. Larson
exaly

